Omeprazole Ab

Omeprazole, the active ingredient in Omeprazole Ab, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazole Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazole Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is used for: - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and healing of erosive esophagitis. - Peptic ulcer disease: promotes ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑associated ulcer prophylaxis: reduces risk of ulcer formation in at‑risk patients. - Erosive gastritis: aids in mucosal healing.

Omeprazole is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild and transient. - Diarrhoea: usually self‑limiting. - Nausea: occasional mild upset. - Abdominal pain: mild cramping. - Flatulence: excess gas. - Constipation: occasional bowel change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low magnesium levels. - Stevens‑Johnson syndrome: severe skin reaction. - Liver enzyme elevation: potential hepatotoxicity. - Fracture risk: increased risk of hip, wrist or spine fractures with long‑term use.

When using Omeprazole, certain precautions should be considered:

- Assess C  :  the   ... (...) - Evaluate "); -  "); -  " "); - “  \